Clinical Study

Corneal Collagen Cross-Linking with Hypoosmolar Riboflavin Solution in Keratoconic Corneas

Figure 3

Bar graph showing the mean best corrected visual acuity (BCVA) of patients before CXL and 6 months and 12 months after CXL with hypoosmolar riboflavin solution. logMAR: logarithm of the minimal angle of resolution.
754182.fig.003